Delay in cART initiation results in persistent immune dysregulation and poor recovery of T-cell phenotype despite a decade of successful HIV suppression

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Ndumbi, Patricia ^a   Falutz, Julian ^a   Pai, Nitika Pant ^a   Tsoukas, Christos M ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DYSREGULATION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; OUTCOME ASSESSMENT; PATIENT CODING; PERIPHERAL LYMPHOCYTE; PHENOTYPE; RETROSPECTIVE STUDY; T LYMPHOCYTE; THERAPY DELAY; TREATMENT DURATION; TREATMENT RESPONSE; VIRUS INHIBITION; VIRUS LOAD; DRUG EFFECTS; HIV INFECTIONS; IMMUNE SYSTEM; IMMUNOLOGY; MIDDLE AGED; PROCEDURES; TIME; TREATMENT OUTCOME;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HUMANS; IMMUNE SYSTEM; MALE; MIDDLE AGED; PHENOTYPE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84899451428     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094018     Document Type: Article

References (42)

1. Stockinger B, Kassiotis G, Bourgeois C (2004) Homeostasis and T cell regulation. Curr Opin Immunol 16: 775-779. (Pubitemid 39423668)
2. Fahey JL, Prince H, Weaver M, Groopman J, Visscher B, et al. (1984) Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders. Am J Med 76: 95-100. (Pubitemid 14216366)
3. Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, et al. (1981) Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 305: 1425-1431. (Pubitemid 12240076)
4. Lo J, Abbara S, Shturman L, Soni A, Wei J, et al. (2010) Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. AIDS 24: 243-253 210.1097/QAD.1090-b1013e328333ea328339e.
5. Malphettes M, Gerard L, Carmagnat M, Mouillot G, Vince N, et al. (2009) Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis 49: 1329-1338.
6. Wikby A, Mansson IA, Johansson B, Strindhall J, Nilsson SE (2008) The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20-100 years of age. Biogerontology 9: 299-308.
7. Adleman LM, Wofsy D (1993) T-cell homeostasis: implications in HIV infection. J Acquir Immune Defic Syndr 6: 144-152. (Pubitemid 23082868)
8. Margolick JB, Donnenberg AD, Muñoz A, Park LP, Bauer KD, et al. (1993) Changes in T and Non-T Lymphocyte Subsets Following Seroconversion to HIV-1: Stable CD3+ and Declining CD3- Populations Suggest Regulatory Responses Linked to Loss of CD4 Lymphocytes. JAIDS Journal of Acquired Immune Deficiency Syndromes 6.
9. Margolick JB, Muñoz A, Donnenberg AD, Park LP, Galai N, et al. (1995) Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. 1: 674-680.
10. Ndumbi P, Gillis J, Raboud J, Klein M, Cooper C, et al. (2013) Clinical impact of altered T-cell homeostasis in treated HIV patients enrolled in a large Canadian Observational Cohort. Aids.
11. Khoruts A, Fraser JM (2005) A causal link between lymphopenia and autoimmunity. Immunol Lett 98: 23-31. (Pubitemid 40409815)
12. Vila LM, Alarcon GS, McGwin G, Jr., Bastian HM, Fessler BJ, et al. (2006) Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Arthritis Rheum 55: 799-806. (Pubitemid 44619195)
13. Zolla-Pazner S, Des Jarlais DC, Friedman SR, Spira TJ, Marmor M, et al. (1987) Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the disease. Proc Natl Acad Sci U S A 84: 5404-5408. (Pubitemid 17129012)
14. Althoff KN, Justice AC, Gange SJ, Deeks SG, Saag MS, et al. (2010) Virologic and immunologic response to HAART, by age and regimen class. Aids 24: 2469-2479.
15. Chattopadhyay PK, Douek DC, Gange SJ, Chadwick KR, Hellerstein M, et al. (2006) Longitudinal assessment of de novo T cell production in relation to HIV-associated T cell homeostasis failure. AIDS Res Hum Retroviruses 22: 501-507.
16. Edelman AS, Zolla-Pazner S (1989) AIDS: a syndrome of immune dysregulation, dysfunction, and deficiency. Faseb J 3: 22-30. (Pubitemid 19042561)
17. Bower JE, Ganz PA, Aziz N, Fahey JL, Cole SW (2003) T-cell homeostasis in breast cancer survivors with persistent fatigue. J Natl Cancer Inst 95: 1165-1168. (Pubitemid 37045395)
18. Ferguson FG, Wikby A, Maxson P, Olsson J, Johansson B (1995) Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol A Biol Sci Med Sci 50: B378-382.
19. Keller M, Lu Y, Lalonde RG, Klein MB (2009) Impact of HIV-1 viral subtype on CD4+ T-cell decline and clinical outcomes in antiretroviral naive patients receiving universal healthcare. Aids 23: 731-737.
20. Kelley CF, Kitchen CM, Hunt PW, Rodriguez B, Hecht FM, et al. (2009) Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis 48: 787-794.
21. Baker JV, Peng G, Rapkin J, Krason D, Reilly C, et al. (2008) Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases. J Acquir Immune Defic Syndr 48: 541-546.
22. Hogg RS, Yip B, Chan KJ, Wood E, Craib KJ, et al. (2001) Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. Jama 286: 2568-2577. (Pubitemid 33096808)
23. Cameron DW, Heath-Chiozzi M, Danner S, Cohen C, Kravcik S, et al. (1998) Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group. Lancet 351: 543-549. (Pubitemid 28077559)
24. Hirsch M, Steigbigel R, Staszewski S, Mellors J, Scerpella E, et al. (1999) A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy. J Infect Dis 180: 659-665. (Pubitemid 29411350)
25. Moore RD, Keruly JC (2007) CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis 44: 441-446. (Pubitemid 46147630)
26. Pakker NG, Notermans DW, De Boer RJ, Roos MTL, Wolf FD, et al. (1998) Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation. 4: 208-214.
27. Strindhall J, Skog M, Ernerudh J, Bengner M, Lofgren S, et al. (2012) The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: the Swedish HEXA immune study. Age (Dordr).
28. Wikby A, Maxson P, Olsson J, Johansson B, Ferguson FG (1998) Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mechanisms of Ageing and Development 102: 187-198. (Pubitemid 28353538)
29. Leung V, Gillis J, Raboud J, Cooper C, Hogg RS, et al. (2013) Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy. PLoS One 8: e77665.
30. Labalette M, Salez F, Pruvot FR, Noel C, Dessaint JP (1994) CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: expansion of an uncommon CD8+ CD57- subset and its progressive replacement by CD8+ CD57+ T cells. Clin Exp Immunol 95: 465-471. (Pubitemid 24210190)
31. Goodrum F, Caviness K, Zagallo P (2012) Human cytomegalovirus persistence. Cell Microbiol 14: 644-655.
32. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, et al. (2006) Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 43: 1143-1151. (Pubitemid 44632796)
33. Naeger DM, Martin JN, Sinclair E, Hunt PW, Bangsberg DR, et al. (2010) Cytomegalovirus-Specific T Cells Persist at Very High Levels during Long-Term Antiretroviral Treatment of HIV Disease. PLoS ONE 5: e8886.
34. Muhlestein JB, Horne BD, Carlquist JF, Madsen TE, Bair TL, et al. (2000) Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 102: 1917-1923.
35. Zhu J, Quyyumi AA, Norman JE, Csako G, Epstein SE (1999) Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels. J Am Coll Cardiol 34: 1738-1743.
36. Gange SJ, Muñoz A, Chmiel JS, Donnenberg AD, Kirstein LM, et al. (1998) Identification of inflections in T-cell counts among HIV-1-infected individuals and relationship with progression to clinical AIDS. Proc Natl Acad Sci U S A 95: 10848-10853. (Pubitemid 28413157)
37. Margolick JB, Donnenberg AD (1997) T-cell homeostasis in HIV-1 infection. Seminars in Immunology 9: 381-388. (Pubitemid 28021496)
38. Carmichael KF, Abayomi A (2006) Analysis of diurnal variation of lymphocyte subsets in healthy subjects in the Caribbean, and its implication in HIV monitoring and treatment. Afr J Med Med Sci 35: 53-57.
39. Malone JL, Simms TE, Gray GC, Wagner KF, Burge JR, et al. (1990) Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important. J Acquir Immune Defic Syndr 3: 144-151. (Pubitemid 20080777)
40. Shete A, Thakar M, Abraham PR, Paranjape R (2010) A review on peripheral blood CD4+ T lymphocyte counts in healthy adult Indians. Indian J Med Res 132: 667-675.
41. Torti C, Prosperi M, Motta D, Digiambenedetto S, Maggiolo F, et al. (2012) Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8 + T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy. Clin Microbiol Infect 18: 449-458.
42. Jain V, Hartogensis W, Bacchetti P, Hunt PW, Hatano H, et al. (2013) Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis 208: 1202-1211.